002317 众生药业
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)3.4046.5348.9737.932-11.240
总资产报酬率 ROA (%)2.4244.3046.0325.737-8.298
投入资产回报率 ROIC (%)2.7234.7986.6566.283-9.917

边际利润分析
销售毛利率 (%)56.08358.59664.85766.79665.337
营业利润率 (%)12.38611.44313.98512.872-17.100
息税前利润/营业总收入 (%)9.63911.50915.90114.731-17.722
净利润/营业总收入 (%)7.1239.57311.78411.308-22.915

收益指标分析
经营活动净收益/利润总额(%)116.108111.06888.538105.659-71.284
价值变动净收益/利润总额(%)15.024-14.7027.290-14.883-69.011
营业外收支净额/利润总额(%)-32.977-5.314-1.618-1.0296.105

偿债能力分析
流动比率 (X)7.7943.9012.9185.0963.823
速动比率 (X)6.6383.3882.4844.2343.330
资产负债率 (%)21.93929.92733.91727.82224.070
带息债务/全部投入资本 (%)-2.30210.78117.49111.050--
股东权益/带息债务 (%)-3,716.362696.408409.311698.178501.764
股东权益/负债合计 (%)343.471225.383189.029254.843306.629
利息保障倍数 (X)29.71917.9007.4367.400-36.152

营运能力分析
应收账款周转天数 (天)75.12967.71866.89466.3780.000
存货周转天数 (天)161.765166.773178.616191.0410.000